Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

High-Density Lipoprotein (HDL) Modulation and Endothelial Function

This study has been completed.
Sponsor:
Collaborator:
Heart and Stroke Foundation of Ontario
Information provided by:
University of Calgary
ClinicalTrials.gov Identifier:
NCT00150722
First received: September 6, 2005
Last updated: November 7, 2008
Last verified: November 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
No publications provided by University of Calgary

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):